Free Trial

Astria Therapeutics (ATXS) Earnings Date, Estimates & Call Transcripts

Astria Therapeutics logo
$4.23 -0.17 (-3.86%)
As of 05/9/2025 04:00 PM Eastern

Astria Therapeutics Earnings Summary

Astria Therapeutics posted Q4 2024 earnings on March 11, 2025, reporting an EPS of -$0.44, which beat the consensus estimate of -$0.45 by $0.01. With a trailing EPS of -$1.67, Astria Therapeutics' earnings are expected to decrease next year, from ($1.65) to ($1.78) per share.

Latest Q4
Earnings Date
Mar. 11Estimated
Consensus EPS
(Mar. 11)
-$0.45
Actual EPS
(Mar. 11)
-$0.44 Beat By $0.01

Q4 2024 Earnings Resources

Get Astria Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Astria Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ATXS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Astria Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.50-$0.46-$0.48
Q2 20252-$0.50-$0.47-$0.49
Q3 20252-$0.51-$0.48-$0.50
Q4 20252-$0.51-$0.48-$0.50

Astria Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/11/2025Q4 2024-$0.45-$0.44+$0.01-$0.44--
8/12/2024Q2 2024-$0.38-$0.43 -$0.05-$0.43--
5/9/2024Q1 2024-$0.35-$0.38 -$0.03-$0.38--
3/4/2024Q4 2023-$0.78-$0.86 -$0.08-$0.86--
11/13/2023Q3 2023-$0.51-$0.63 -$0.12-$0.63--
8/7/2023Q2 2023-$0.50-$0.45+$0.05-$0.45--
5/11/2023Q1 2023-$0.51-$0.40+$0.11-$0.40--

Astria Therapeutics Earnings - Frequently Asked Questions

Astria Therapeutics (NASDAQ:ATXS) last announced its quarterly earning data on Tuesday, March 11, 2025. Learn more on ATXS's earnings history.

In the previous quarter, Astria Therapeutics (NASDAQ:ATXS) reported ($0.44) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.01. Learn more on analysts' earnings estimate vs. ATXS's actual earnings.

Astria Therapeutics (NASDAQ:ATXS) has a recorded net income of -$72.89 million. ATXS has generated -$1.67 earnings per share over the last four quarters.

Astria Therapeutics's earnings are expected to decrease from ($1.65) per share to ($1.78) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ATXS) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners